©The Author(s) 2025.
World J Transplant. Dec 18, 2025; 15(4): 107461
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.107461
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.107461
Table 1 Baseline characteristics of adult liver transplantation patients with aminotransferase > 5000 U/L, n (%)
| Number | 25 |
| Age (years), median (IQR) | 54 (45-60) |
| Male sex | 13 (52) |
| Etiology of liver disease | |
| Hepatitis C virus | 14 (56) |
| Hepatitis B virus | 2 (8) |
| Alcohol | 2 (8) |
| Biliary | 2 (8) |
| Acute liver failure | 2 (8) |
| Polycystic liver disease | 1 (4) |
| Metabolic-dysfunction-associated fatty liver disease | 1 (4) |
| Autoimmune hepatitis | 1 (4) |
| Child-Pugh-Turcotte classification | |
| A | 9 (36) |
| B | 9 (36) |
| C | 7 (28) |
| Model for end stage liver disease-Na, median (IQR) | 13 (10-17) |
| Aspartate aminotransferase | 8053 (6730-11340) |
| Alanine aminotransferase | 4135 (2980-6414) |
| Serum factor V | 28 (14-46) |
| Arterial lactate | 4.4 (2.6-11.6) |
- Citation: Lazzarotto-da-Silva G, Chaves BM, Feier FH, Rodrigues PD, Grezzana-Filho TJM, de Araujo A, Alvares-da-Silva MR, Marchiori RC, Chedid MF, Kruel CRP. Serum factor V and arterial lactate levels predict graft survival in liver transplant recipients with aminotransferase above five thousand. World J Transplant 2025; 15(4): 107461
- URL: https://www.wjgnet.com/2220-3230/full/v15/i4/107461.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i4.107461